Codexis, Inc. (NASDAQ:CDXS) - Codexis: Q4 Earnings Insights
Price action over last quarter: Up 46.48% Company Profile Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.
Source: benzinga.com